- Home
- MDAI vs VRCA Comparison
MDAI vs VRCA Comparison
Compare MDAI & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDAI
- VRCA
- Stock Information
- Founded
- MDAI 2013
- VRCA 2013
- Country
- MDAI United States
- VRCA United States
- Employees
- MDAI N/A
- VRCA N/A
- Industry
- MDAI Medical/Dental Instruments
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- MDAI Health Care
- VRCA Health Care
- Exchange
- MDAI Nasdaq
- VRCA Nasdaq
- Market Cap
- MDAI 51.5M
- VRCA 54.0M
- IPO Year
- MDAI N/A
- VRCA 2018
- Fundamental
- Price
- MDAI $2.68
- VRCA $0.60
- Analyst Decision
- MDAI Strong Buy
- VRCA Hold
- Analyst Count
- MDAI 2
- VRCA 5
- Target Price
- MDAI $4.75
- VRCA $6.00
- AVG Volume (30 Days)
- MDAI 503.5K
- VRCA 427.9K
- Earning Date
- MDAI 08-11-2025
- VRCA 08-13-2025
- Dividend Yield
- MDAI N/A
- VRCA N/A
- EPS Growth
- MDAI N/A
- VRCA N/A
- EPS
- MDAI N/A
- VRCA N/A
- Revenue
- MDAI $29,962,000.00
- VRCA $7,179,000.00
- Revenue This Year
- MDAI N/A
- VRCA $171.87
- Revenue Next Year
- MDAI $15.14
- VRCA $71.38
- P/E Ratio
- MDAI N/A
- VRCA N/A
- Revenue Growth
- MDAI 55.21
- VRCA N/A
- 52 Week Low
- MDAI $0.82
- VRCA $0.38
- 52 Week High
- MDAI $3.25
- VRCA $8.98
- Technical
- Relative Strength Index (RSI)
- MDAI 74.34
- VRCA 50.07
- Support Level
- MDAI $2.07
- VRCA $0.52
- Resistance Level
- MDAI $2.22
- VRCA $0.67
- Average True Range (ATR)
- MDAI 0.16
- VRCA 0.06
- MACD
- MDAI 0.03
- VRCA -0.01
- Stochastic Oscillator
- MDAI 95.71
- VRCA 30.87
About MDAI Spectral AI Inc.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.